Biocon Stock Screener | Share Price & Fundamental Analysis
BIOCON
Pharmaceuticals
Screen Biocon share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹387.05
▲
1.90 (0.49%)
Share Price BSE
₹387.20
▲
2.15 (0.56%)
Market Cap
₹51,493.20 Cr.
P/E Ratio (TTM)
67.55
P/B Ratio
1.92
EPS (TTM)
₹8.46
Dividend Yield
0.12%
Debt to Equity
0.84
52W High
₹421.60
52W Low
₹302.45
Operating Margin
23.00%
Profit Margin
10.40%
Revenue (TTM)
₹4,415.00
EBITDA
₹1,077.00
Net Income
₹459.00
Total Assets
₹58,797.00
Total Equity
₹27,713.00
Biocon Share Price History - Stock Screener Chart
Screen BIOCON historical share price movements with interactive charts. Analyze price trends and patterns.
Biocon Company Profile - Fundamental Screener
Screen Biocon company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BIOCON shares.
Biocon Limited is India's largest fully-integrated biopharmaceutical company, focusing on biotechnology products and research services. Founded in 1978, Biocon specializes in treating diabetes, cancer, and autoimmune diseases. The company develops and commercializes novel biologics, biosimilars, complex small molecule APIs, and generic formulations for global markets. Biocon's product portfolio includes cardiology,...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Kiran Mazumdar Shaw
ISIN
INE376G01013
Website
https://www.biocon.com
Biocon Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BIOCON balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 58,797 | 56,071 | 52,043 | 20,394 | 18,522 | 14,444 | 12,192 | 9,990 | 9,394 | 8,458 |
| Current Assets | 16,286 | 15,179 | 12,334 | 8,382 | 7,600 | 5,325 | 4,823 | 4,149 | 4,048 | 3,971 |
| Fixed Assets | 31,963 | 30,644 | 29,468 | 6,569 | 6,364 | 5,971 | 4,471 | 3,700 | 3,626 | 1,749 |
| Liabilities | ||||||||||
| Total Liabilities | 58,797 | 56,071 | 52,043 | 20,394 | 18,522 | 14,444 | 12,192 | 9,990 | 9,394 | 8,458 |
| Current Liabilities | 16,751 | 15,437 | 21,043 | 7,096 | 5,805 | 3,053 | 2,448 | 2,200 | 2,502 | 2,493 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 27,713 | 25,275 | 22,489 | 9,470 | 8,508 | 7,383 | 6,707 | 5,649 | 5,214 | 4,300 |
| Share Capital | 600 | 600 | 600 | 600 | 600 | 600 | 300 | 300 | 100 | 100 |
| Reserves & Surplus | 21,044 | 19,183 | 17,267 | 7,832 | 7,027 | 6,106 | 5,798 | 4,881 | 4,738 | 3,992 |
Screen BIOCON income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,415 | 3,990 | 4,356 | 3,912 | 4,543 | 3,604 | 3,826 | 3,929 | 3,516 | 3,551 | 4,135 | 2,476 | 2,217 | 2,384 | 3,020 |
| Expenses | 3,339 | 3,193 | 3,472 | 3,013 | 2,813 | 2,905 | 3,070 | 2,820 | 2,741 | 2,769 | 3,051 | 1,911 | 1,783 | 1,894 | 2,624 |
| EBITDA | 1,077 | 797 | 884 | 900 | 1,730 | 699 | 756 | 1,109 | 775 | 782 | 1,084 | 565 | 434 | 490 | 396 |
| Operating Profit % | 23.00% | 18.00% | 19.00% | 22.00% | 17.00% | 18.00% | 19.00% | 25.00% | 20.00% | 18.00% | 14.00% | 21.00% | 17.00% | 18.00% | 11.00% |
| Depreciation | 436 | 455 | 473 | 407 | 405 | 420 | 425 | 364 | 358 | 389 | 415 | 212 | 218 | 231 | 301 |
| Interest | 212 | 277 | 272 | 227 | 236 | 226 | 223 | 249 | 233 | 248 | 267 | 11 | 20 | 30 | 120 |
| Profit Before Tax | 487 | 97 | 171 | 319 | 1,146 | 98 | 156 | 497 | 184 | 214 | 808 | 343 | 197 | 229 | -26 |
| Tax | 27 | 8 | 39 | 96 | 284 | 71 | 75 | 82 | 35 | 42 | 55 | 59 | 30 | 147 | -5 |
| Net Profit | 459 | 89 | 133 | 223 | 862 | 27 | 81 | 415 | 149 | 173 | 753 | 284 | 167 | 82 | -21 |
| EPS | 2.88 | 0.26 | 0.66 | 1.13 | 5.51 | -0.13 | 0.21 | 2.62 | 0.85 | 1.05 | 5.52 | 2.00 | 1.21 | 0.39 | -0.35 |
Biocon Cash Flow Screener - Liquidity Fundamentals
Screen BIOCON cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 4,061 | 2,954 | 1,853 | 1,177 | 1,160 | 1,283 | 1,155 | 662 | 640 | 371 |
| Investing Activities | -203 | -1,002 | -14,260 | -1,662 | -3,651 | -1,505 | -703 | -684 | -510 | -1,138 |
| Financing Activities | -1,854 | -2,333 | 13,049 | 242 | 2,564 | 388 | -242 | -240 | -178 | 1,068 |
| Net Cash Flow | 2,004 | -380 | 641 | -243 | 72 | 165 | 210 | -261 | -47 | 300 |
Screen BIOCON shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 60.64% | 54.45% | 54.45% | 60.64% | 60.64% | 60.64% | 60.64% | 60.64% |
| FII Holding | 5.66% | 6.04% | 6.61% | 5.63% | 5.90% | 5.93% | 5.66% | 0.00% |
| DII Holding | 15.72% | 22.82% | 22.10% | 13.68% | 14.30% | 14.44% | 15.37% | 11.90% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.63% | 12.58% | 12.71% | 15.53% | 14.63% | 14.57% | 14.07% | 13.21% |
| Other Holding | 4.34% | 4.10% | 4.12% | 4.52% | 4.53% | 4.42% | 4.27% | 14.26% |
| Shareholder Count | 424,297 | 430,217 | 413,191 | 470,261 | 443,513 | 439,503 | 427,705 | 411,086 |
Biocon Dividend Screener - Share Yield Analysis
Screen BIOCON dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.50 | 0.13% |
| 2024-March | ₹0.50 | 0.15% |
| 2023-March | ₹1.50 | 0.57% |
| 2022-March | ₹0.50 | 0.25% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 0.37% |
| 2018-March | ₹1.00 | 0.33% |
| 2017-March | ₹3.00 | 1.01% |
Biocon Index Membership - Market Screener Classification
Screen BIOCON by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Biocon Market Events Screener - Corporate Actions
Screen BIOCON market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-31 | 2026-12-31 | Extraordinary General Meeting | NA | -0.61% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 8.49% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 5.11% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -3.08% |
| 2025-07-04 | 2025-07-04 | Dividend | ₹ 0.50 /share | 8.05% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | 2.18% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -4.63% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | -11.82% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 8.75% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 0.50 /share | 15.77% |
| 2023-07-07 | 2023-07-07 | Dividend | ₹ 1.50 /share | 7.92% |
| 2022-06-30 | 2022-07-01 | Dividend | ₹ 0.50 /share | -19.33% |
| 2019-06-12 | 2019-06-13 | Bonus | 1:1 | -4.99% |
Biocon Competitors Screener - Peer Comparison
Screen BIOCON competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 422,331 | 40.28 | 54,729 | 9.71% | 10,980 | 53.13 |
| Divis Laboratories | 176,338 | 70.98 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 133,239 | 62.26 | 11,539 | 6.99% | 1,911 | 71.28 |
| Cipla | 123,654 | 22.75 | 28,410 | 7.12% | 5,291 | 57.84 |
| Dr Reddys Laboratories | 104,846 | 18.27 | 33,741 | 16.73% | 5,725 | 46.16 |
| Lupin | 98,198 | 22.61 | 22,910 | 13.74% | 3,306 | 63.46 |
| Zydus Life Science | 93,685 | 18.63 | 23,511 | 18.55% | 4,615 | 54.52 |
| Mankind Pharma | 92,501 | 52.17 | 12,744 | 20.90% | 2,007 | 56.13 |
| Aurobindo Pharma | 71,514 | 20.91 | 32,346 | 9.43% | 3,484 | 60.21 |
| Alkem Laboratories | 67,620 | 28.04 | 13,458 | 3.70% | 2,216 | 55.49 |
Biocon Company Announcements - News Screener
Screen BIOCON latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-07 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2026-01-06 | Intimation Of Early Full Redemption Of Ncds By The Company | View |
| 2026-01-03 | Issue Of Commercial Papers Of Rs. 200 Crores | View |
| 2026-01-02 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-01-01 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-24 | Intimation Of Record Date For Commercial Paper | View |
| 2025-12-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-22 | Issue Of Commercial Papers | View |
| 2025-12-18 | Notification To Stock Exchanges | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |